Cargando…

Tissue-specific Tregs in cancer metastasis: opportunities for precision immunotherapy

Decades of advancements in immuno-oncology have enabled the development of current immunotherapies, which provide long-term treatment responses in certain metastatic cancer patients. However, cures remain infrequent, and most patients ultimately succumb to treatment-refractory metastatic disease. Re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huppert, Laura A., Green, Michael D., Kim, Luke, Chow, Christine, Leyfman, Yan, Daud, Adil I., Lee, James C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752797/ https://www.ncbi.nlm.nih.gov/pubmed/34417572 http://dx.doi.org/10.1038/s41423-021-00742-4

Ejemplares similares

The Liver–Immunity Nexus and Cancer Immunotherapy
por: Lee, James C., et al.
Publicado: (2022)

Intratumoral therapies and in-situ vaccination for melanoma
por: Huppert, Laura A., et al.
Publicado: (2022)

Antigen-Specific Treg Therapy in Type 1 Diabetes – Challenges and Opportunities
por: Serr, Isabelle, et al.
Publicado: (2021)

Optimizing human Treg immunotherapy by Treg subset selection and E-selectin ligand expression
por: Donnelly, Conor, et al.
Publicado: (2018)

Opportunities for Treg cell therapy for the treatment of human disease
por: Bluestone, Jeffrey A., et al.
Publicado: (2023)

Tissue Tregs and Maintenance of Tissue Homeostasis
por: Shao, Qing, et al.
Publicado: (2021)

Treg-based immunotherapy for antigen-specific immune suppression and stable tolerance induction: a perspective
por: Sakaguchi, Shimon, et al.
Publicado: (2023)

Metabolic Control of Treg Cell Stability, Plasticity, and Tissue-Specific Heterogeneity
por: Shi, Hao, et al.
Publicado: (2019)

Immunometabolic Checkpoints of Treg Dynamics: Adaptation to Microenvironmental Opportunities and Challenges
por: Pacella, Ilenia, et al.
Publicado: (2019)

Treg Depletion Inhibits Efficacy of Cancer Immunotherapy: Implications for Clinical Trials
por: Curtin, James F., et al.
Publicado: (2008)

Human Tregs Made Antigen Specific by Gene Modification: The Power to Treat Autoimmunity and Antidrug Antibodies with Precision
por: Adair, Patrick R., et al.
Publicado: (2017)

Chimeric antigen receptors: unleashing a new age of anti-cancer therapy
por: Leyfman, Yan
Publicado: (2018)

Patient-Derived Tumor Organoids: New Progress and Opportunities to Facilitate Precision Cancer Immunotherapy
por: Wang, Ji, et al.
Publicado: (2022)

FoxP3 Tregs Response to Sublingual Allergen Specific Immunotherapy in Children Depends on the Manifestation of Allergy
por: Stelmaszczyk-Emmel, Anna, et al.
Publicado: (2015)

Modeling the Th17 and Tregs Paradigm: Implications for Cancer Immunotherapy
por: Corral-Jara, Karla F., et al.
Publicado: (2021)

Human Tregs at the materno-fetal interface show site-specific adaptation reminiscent of tumor Tregs
por: Wienke, Judith, et al.
Publicado: (2020)

Hyperprogression of Liver Metastasis With Neoadjuvant Immunotherapy for Soft Tissue Sarcoma
por: Chan, Abigail S, et al.
Publicado: (2020)

Profiling of Tregs across tissues reveals plasticity in ST2 expression and hierarchies in tissue-specific phenotypes
por: Spath, Sabine, et al.
Publicado: (2022)

IL-2 availability regulates the tissue specific phenotype of murine intra-hepatic Tregs
por: Kurt, Ada S., et al.
Publicado: (2022)

Sublingual immunotherapy increases Treg/Th17 ratio in allergic rhinitis
por: Wang, Jiarong, et al.
Publicado: (2021)

Cytokine and metabolic regulation of adipose tissue Tregs
por: Elkins, Cody, et al.
Publicado: (2022)

Gene expression pattern of Treg and TCR Vγ subfamily T cells before and after specific immunotherapy in allergic rhinitis
por: Zheng, Rui, et al.
Publicado: (2014)

Precision Immunotherapy for Sepsis
por: Peters van Ton, Annemieke M., et al.
Publicado: (2018)

Tissue Treg Secretomes and Transcription Factors Shared With Stem Cells Contribute to a Treg Niche to Maintain Treg-Ness With 80% Innate Immune Pathways, and Functions of Immunosuppression and Tissue Repair
por: Zhang, Ruijing, et al.
Publicado: (2021)

Advances in Human Immune System Mouse Models for Personalized Treg-Based Immunotherapies
por: Serr, Isabelle, et al.
Publicado: (2021)

Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas
por: Amoozgar, Zohreh, et al.
Publicado: (2021)

Reprogramming of Treg cells in the inflammatory microenvironment during immunotherapy: a literature review
por: Wu, Xinyan, et al.
Publicado: (2023)

Commentary: Precision Immunotherapy for Sepsis
por: Zijlstra, Jan G., et al.
Publicado: (2019)

Multimodal predictors for precision immunotherapy
por: Roelofsen, L.M., et al.
Publicado: (2022)

Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis
por: Knitz, Michael W, et al.
Publicado: (2021)

Leveraging the Treg-intrinsic CTLA4–PKCη signaling pathway for cancer immunotherapy
por: Liu, Hsin-Yu, et al.
Publicado: (2021)

Exosome-Modified Liposomes Targeted Delivery of Thalidomide to Regulate Treg Cells for Antitumor Immunotherapy
por: Yang, Yang, et al.
Publicado: (2023)

Precision intervention of cell type-specific targeting is required for future cancer immunotherapy
por: Cai, Yitong, et al.
Publicado: (2023)

Antigen Specificity Enhances Disease Control by Tregs in Vitiligo
por: Mukhatayev, Zhussipbek, et al.
Publicado: (2020)

Organ-Specific and Memory Treg Cells: Specificity, Development, Function, and Maintenance
por: Gratz, Iris K., et al.
Publicado: (2014)

Development of Beta-Amyloid-Specific CAR-Tregs for the Treatment of Alzheimer’s Disease
por: Saetzler, Valerie, et al.
Publicado: (2023)

Ubiquitin-specific peptidase 18 regulates the differentiation and function of Treg cells
por: Yang, Lu, et al.
Publicado: (2020)

Regulation of Treg Cell Metabolism and Function in Non-Lymphoid Tissues
por: Yang, Kai
Publicado: (2022)

Pediatric Cancer Immunotherapy: Opportunities and Challenges
por: Wedekind, Mary Frances, et al.
Publicado: (2018)

New opportunities for nanoparticles in cancer immunotherapy
por: Park, Wooram, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qi32jq3auu767djv8a8q0i9v88